SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-16-020493
Filing Date
2016-09-22
Accepted
2016-09-22 11:49:34
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A apvo-10qa_20160630.htm 10-Q/A 1499151
2 EX-31.1 apvo-ex311_9.htm EX-31 17921
3 EX-31.2 apvo-ex312_7.htm EX-31 17972
4 EX-32.1 apvo-ex321_8.htm EX-32 9275
5 EX-32.2 apvo-ex322_6.htm EX-32 9282
  Complete submission text file 0000950123-16-020493.txt   3845392

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apvo-20160630.xml EX-101.INS 539226
7 XBRL TAXONOMY EXTENSION SCHEMA apvo-20160630.xsd EX-101.SCH 35765
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20160630_cal.xml EX-101.CAL 35325
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20160630_def.xml EX-101.DEF 73752
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20160630_lab.xml EX-101.LAB 217343
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20160630_pre.xml EX-101.PRE 167943
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37746 | Film No.: 161897095
SIC: 2834 Pharmaceutical Preparations